HealthEquity, Inc. (HQY) financial statements and ratios from SEC XBRL: revenue $1.31B (TTM), net margin 16.4%, revenue growth 7.2% YoY, P/E 38.2. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.31B |
| Net Margin | 16.4% |
| Revenue Growth (YoY) | 7.2% |
| EPS Growth (YoY) | 32.3% |
| FCF Growth (YoY) | 50.3% |
| P/E Ratio | 38.2 |
| EV / EBITDA | 19.1 |
| Price / Book | 4.30 |
| Price / Sales | 6.59 |
| FCF Yield | 5.5% |
| DCF Value (model) | $30.54 |
| DCF Upside vs Price | -71.0% |
| Altman Z-Score | 5.11 (safe) |
| Piotroski F-Score | 9/9 |
| Sector P/E (Technology) | 33.9 |
HQY overview · HQY earnings · HQY KPIs · HQY investor relations · HQY ownership · HQY peers · HQY filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.